Aminov Erez — SEC Form 4 filings
SEC reporting owner CIK 1986112. 13 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-27 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 1 filing — 8,700 shares, $8,176 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 100,000 shares, $133,649 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 55,410 shares @ $1.39 ($77,020) in MIRA PHARMACEUTICALS, INC., filed 2024-11-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | Chief Executive Officer, Director | 9 | 8 legs · 8,700 sh · $8,176 | 2 legs · 100,000 sh · $133,649 | 9 |
| Telomir Pharmaceuticals, Inc. (TELO) | CEO and Chairman, Director | 4 | — | — | 8 |
Form 4 filings — Aminov Erez
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/award (A): 1,960,170 (derivative) · Disposition to issuer (D): 1,960,170 (derivative) · Grant/award (A): 2,000,000 (derivative) · Disposition to issuer (D): 2,000,000 (derivative) | EDGAR |
| 2026-04-24 | 4 | Telomir Pharmaceuticals, Inc. (TELO) | Other (J): 7,319,710 @ $1.37 | EDGAR |
| 2026-04-01 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 83,500 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 2,685,456 | EDGAR |
| 2025-09-18 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 62,500 @ $1.37 | EDGAR |
| 2025-05-30 | 4 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 2,000,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Sale (S): 55,410 @ $1.39 · Sale (S): 44,590 @ $1.27 | EDGAR |
| 2024-08-29 | 4 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/award (A): 1,960,170 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 379,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Purchase (P): 2,000 @ $1 · Purchase (P): 1,000 @ $1.03 · Purchase (P): 500 @ $1.02 · Purchase (P): 2,000 @ $0.84 · Purchase (P): 1,000 @ $0.85 · Purchase (P): 600 @ $0.87 · +2 more | EDGAR |
| 2024-03-27 | 4 | MIRA PHARMACEUTICALS, INC. (MIRA) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1986112 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →